Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Aurobindo Pharma Ltd.
NSE: AUROPHARMA
|
BSE: 524804
|
ISIN: INE406A01037
|
Industry: Pharmaceuticals
|
Mid-range Performer
1172.9000
-25.80
(
-2.15
%)
NSE
Jan 12, 2026
15:31 PM
Volume:
689.1K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Aurobindo Pharma Ltd.
28 May 2025
1172.90
-2.15%
Result Update:Aurobindo Pharma
Buy:
Aurobindo Pharma Ltd.
by
Axis Direct
Target: 1500 | Upside : 27.9%
Axis Direct
We maintain our BUY recommendation on Aurobindo Pharma with a TP of Rs 1,500/share.
Aurobindo Pharma Ltd.'s price crossed below 50Day SMA today
More from Aurobindo Pharma Ltd.
Recommended
IPO wave continues as Amagi Media and Five SMEs open for subscription
|
12 Jan 2026, 06:40PM
Market closes higher, supported by reassuring comments from US Ambassador Sergio Gor on India-US trade ties
Trendlyne Marketwatch |
12 Jan 2026, 04:04PM
A deal is called off, increasing the chance for Aurobindo Pharma to be debt free
|
15 Jul 2020